AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings Guidance

Axogen, Inc. Reports 2019 Second Quarter Financial ResultsAugust 6, 2019 4:02 PM